➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Boehringer Ingelheim
Moodys
Mallinckrodt
Express Scripts

Last Updated: May 11, 2021

DrugPatentWatch Database Preview

Baxter Hlthcare Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Baxter Hlthcare
International Patents:82
US Patents:15
Tradenames:316
Ingredients:117
NDAs:203

Drugs and US Patents for Baxter Hlthcare

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K) dextrose; potassium chloride; sodium chloride INJECTABLE;INJECTION 018037-001 Approved Prior to Jan 1, 1982 AP RX No No   Get Started for $10   Get Started for $10
Baxter Hlthcare HEPARIN SODIUM 25,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER heparin sodium INJECTABLE;INJECTION 018814-003 Jul 9, 1985 DISCN No No   Get Started for $10   Get Started for $10
Baxter Hlthcare DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 017512-007 Jul 9, 1984 DISCN No No   Get Started for $10   Get Started for $10
Baxter Hlthcare CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER amino acids; dextrose INJECTABLE;INJECTION 020734-002 Sep 29, 1997 RX No No   Get Started for $10   Get Started for $10
Baxter Hlthcare Corp FLUCONAZOLE IN SODIUM CHLORIDE 0.9% fluconazole INJECTABLE;INJECTION 077947-001 May 26, 2010 AP RX No No   Get Started for $10   Get Started for $10
Baxter Hlthcare CEFTRIAXONE IN PLASTIC CONTAINER ceftriaxone sodium INJECTABLE;INJECTION 065224-001 Aug 23, 2005 RX No Yes   Get Started for $10   Get Started for $10
Baxter Hlthcare Corp NOURESS cysteine hydrochloride SOLUTION;INTRAVENOUS 212535-001 Dec 13, 2019 DISCN Yes No 10,918,662   Get Started for $10 Y   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Baxter Hlthcare

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare IFEX/MESNEX KIT ifosfamide; mesna INJECTABLE;INJECTION 019763-004 Oct 10, 1992 4,882,452   Get Started for $10
Baxter Hlthcare Corp TRANSDERM SCOP scopolamine SYSTEM;TRANSDERMAL 017874-001 Approved Prior to Jan 1, 1982 4,436,741   Get Started for $10
Baxter Hlthcare ETHRANE enflurane LIQUID;INHALATION 017087-001 Approved Prior to Jan 1, 1982 3,527,813   Get Started for $10
Baxter Hlthcare Corp DOXIL (LIPOSOMAL) doxorubicin hydrochloride INJECTABLE, LIPOSOMAL;INJECTION 050718-001 Nov 17, 1995 5,013,556   Get Started for $10
Baxter Hlthcare SUPRANE desflurane LIQUID;INHALATION 020118-001 Sep 18, 1992 4,762,856*PED   Get Started for $10
Baxter Hlthcare BREVIBLOC esmolol hydrochloride INJECTABLE;INJECTION 019386-003 Aug 15, 1988 4,387,103   Get Started for $10
Baxter Hlthcare IFEX/MESNEX KIT ifosfamide; mesna INJECTABLE;INJECTION 019763-004 Oct 10, 1992 5,696,172   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for BAXTER HLTHCARE drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 10 mg/mL, 250 mL infusion bags and 20 mg/mL, 100 mL infusion bags ➤ Subscribe 2014-01-31
➤ Subscribe Inhalation 99.90% ➤ Subscribe 2008-09-11

International Patents for Baxter Hlthcare Drugs

Country Patent Number Estimated Expiration
Denmark 2402008   Get Started for $10
World Intellectual Property Organization (WIPO) 2009134347   Get Started for $10
Slovenia 1368019   Get Started for $10
European Patent Office 2402008   Get Started for $10
Eurasian Patent Organization 031355   Get Started for $10
Portugal 1368019   Get Started for $10
Japan 2017019879   Get Started for $10
>Country >Patent Number >Estimated Expiration

Supplementary Protection Certificates for Baxter Hlthcare Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1280520 92678 Luxembourg   Get Started for $10 PRODUCT NAME: TOBRAMYCINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE QUI EN DERIVE. FIRST REGISTRATION: 20110725
1499331 122014000007 Germany   Get Started for $10 PRODUCT NAME: NATRIUMSULFAT, MAGNESIUMSULFAT UND KALIUMSULFAT; NAT. REGISTRATION NO/DATE: 86203.00.00 20130808; FIRST REGISTRATION: BELGIEN BE434323 20130220
2203431 15C0013 France   Get Started for $10 PRODUCT NAME: DASABUVIR OU UN SEL DE CELUI-CI, NOTAMMENT LE SEL DE SODIUM; REGISTRATION NO/DATE: EU/1/14/983 20150119
0484186 SPC/GB11/055 United Kingdom   Get Started for $10 PRODUCT NAME: 4-AMINOPYRIDINE OR A SALT THEREOF; REGISTERED: UK EU/1/11/699/001 20110720; UK EU/1/11/699/002 20110720
1718641 SPC/GB12/028 United Kingdom   Get Started for $10 PRODUCT NAME: AZILSARTAN MEDOXOMIL AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING THE POTASSIUM SALT; REGISTERED: UK EU/1/11/734/001-011 20111209
1948158 1690020-1 Sweden   Get Started for $10 PRODUCT NAME: SACUBITRIL AND VALSARTAN, AS SACUBITRIL VALSARTAN SODIUM SALT COMPLEX, I.E. TRISODIUM 3-((1S,3R)-1-BIPHENYL-4-YLMETHYL-3- ETHOXYCARBONYL-1-BUTYLCARBAMOYL)PROPIONATE-(S)-3-METHYL-2- (PENTANOYL2-(TETRAZOL-5-YLATE)BIPHENYL-4- YLMETHYLAMINO)BUTYRATE HEMIPENTAHYDRATE; REG. NO/DATE: EU/1/15/1058 20151123
0984957 1290006-4 Sweden   Get Started for $10 PRODUCT NAME: ACETYLSALICYLSYRA OCH ESOMEPRAZOLMAGNESIUMTRIHYDRAT; NAT. REG. NO/DATE: MTNR 44371 20110930; FIRST REG.: PT 5402359MFL 20110812
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Colorcon
AstraZeneca
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.